retatrutide safety More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase retatrutide safety profile clinical trials

Hexarelin: the special case of CD36 Hexapeptide His-D-2Me-Trp-Ala-Trp-D-Phe-Lys-NH

Danelsdttir HB, Aspelund T, Shen Q, Halldorsdottir T, Jakobsdttir J, Song H, et al

Albumin increased fungal cytotoxicity, particularly of otherwise low damaging clinical isolates, whereas results were less consistent with SC5314, likely due to albumin neutralizing candidalysin 19 of this highly efficient toxin producing strain 3

Note: It is strongly advised that individuals consult a healthcare professional prior to initiating any supplement, particularly if they have existing health conditions, are taking prescribed medications, or are pregnant.